WOODSTOCK CORP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOODSTOCK CORP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,456,499
+12.1%
14,2850.0%0.17%
+3.6%
Q1 2023$1,298,792
+139.3%
14,2850.0%0.17%
+130.6%
Q4 2022$542,687
+47.1%
14,285
-2.7%
0.07%
+30.9%
Q3 2022$369,000
-9.8%
14,685
+9.0%
0.06%
-3.5%
Q2 2022$409,000
-7.3%
13,4730.0%0.06%
+9.6%
Q1 2022$441,000
+18.2%
13,473
-4.7%
0.05%
+33.3%
Q4 2021$373,000
-87.4%
14,137
-52.0%
0.04%
-88.7%
Q3 2021$2,965,000
-24.2%
29,470
+6.7%
0.35%
-24.8%
Q2 2021$3,910,000
+84.9%
27,630
+30.2%
0.46%
+71.0%
Q1 2021$2,115,000
-18.8%
21,217
+0.7%
0.27%
-22.9%
Q4 2020$2,604,000
+22.1%
21,067
-3.8%
0.35%
+1.5%
Q3 2020$2,133,000
-9.5%
21,892
+44.9%
0.34%
-14.4%
Q2 2020$2,357,000
+8.1%
15,1090.0%0.40%
-9.5%
Q1 2020$2,181,000
-29.4%
15,1090.0%0.44%
-11.7%
Q4 2019$3,089,000
+86.5%
15,109
-26.7%
0.50%
+74.0%
Q3 2019$1,656,000
-14.9%
20,6240.0%0.29%
-15.0%
Q2 2019$1,946,000
+10.4%
20,6240.0%0.34%
+7.6%
Q1 2019$1,763,000
+52.4%
20,6240.0%0.32%
+36.2%
Q4 2018$1,157,000
-31.4%
20,6240.0%0.23%
-18.6%
Q3 2018$1,686,000
+103.1%
20,624
-13.1%
0.28%
+86.3%
Q2 2018$830,000
+104.9%
23,730
+20.1%
0.15%
+98.7%
Q1 2018$405,000
-5.4%
19,752
+30.7%
0.08%
-2.5%
Q4 2017$428,00015,1160.08%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders